PCF Young Investigator Dr. Ashwin Sachdeva and Prof. Noel Clarke of the University of Manchester in the UK discussed their recently published work showing that the risk of cardiovascular events (e.g. heart attack, stroke, blood clots) nearly doubled among patients taking ARSIs in addition to standard hormone therapy.
Watch the video to learn more about:
- How you and your doctor can consider your personal risk factors when starting treatment
- Why it’s important to work with a team – urologist, medical oncologist, primary care physician – to monitor your health
- Ways to lower your risk of cardiovascular events
Find more resources on nutrition and exercise here: